Rapid POC Diagnostics in Vet Medicine

by | Jan 25, 2021 | Veterinary Diagnostics

Home » Veterinary Diagnostics » Rapid POC Diagnostics in Vet Medicine
IVC Journal Cover POC Diagnostics

Dr. Sam Stewart, DVM from Ethos, describes the benefits of rapid POC diagnostics in veterinary medicine. Ethos will implement LexaGene‘s MiQLab to help deliver innovative evidence-based patient care.

Veterinary medicine has a significant need for in-clinic point-of-care (POC) tests that can deliver rapid, reference lab quality sensitivity and specificity data.

In the veterinary clinic setting, rapid point-of-care tests allow for accurate insights to be derived from the results, so clinicians have more confidence in their prescribed treatment plans. Furthermore, the rapid nature of this type of testing lends itself to producing results in real time, possibly while the patient is still in the hospital, removing the impact of time delays experienced with traditional reference laboratory testing methods. These innovations are on the cutting edge of both veterinary and human diagnostics.


In veterinary medicine, clinicians rely on available diagnostic technologies to confirm diagnoses and provide clinical insight into patient care. In the case of suspected bacterial infections, culture and susceptibility (C&S) tests are routinely ordered to provide definitive insight into the causative pathogens, and to determine whether antimicrobial resistance is present. Commonly, however, the need to make treatment decisions often precedes obtainment of the C&S results, requiring antibiotics to be prescribed empirically in order to address the suspected infection, improve the patient’s symptoms, and to give the client peace of mind that their pet has been offered
solutions-focused patient care. Once the C&S results are received, the empiric antibiotic selection is either confirmed as effective, or if resistance is demonstrated, the antibiotic is changed.

Read full article below

The article is from fall 2020 IVC Journal vol. 10 issue 4.

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>


LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.

The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants

LexaGene’s MiQLab™ System is the only fully automated system on the market today that is equipped with a disposable filter-based sample preparation cartridge that allows for efficient processing of large volumes of sample for sensitive detection of contaminants.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

Upcoming Events

LexaGene will be exhibiting AAHA's Connexity Event in September.
1 2 3 8

Latest Resources

In this webinar, Dr. Jane Sykes details data from a multi-center study using the MiQLab® System for diagnosing urinary tract infections.
1 2 3 28